| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.29▼ | 4.34▼ | 4.34▼ | 4.21▼ | 3.83▲ |
| MA10 | 4.34▼ | 4.32▼ | 4.31▼ | 4.16▼ | 3.44▲ |
| MA20 | 4.31▼ | 4.28▼ | 4.24▼ | 3.93▲ | 2.50▲ |
| MA50 | 4.26▼ | 4.23▼ | 4.22▼ | 3.34▲ | 3.28▲ |
| MA100 | 4.24▼ | 4.16▲ | 4.00▲ | 2.45▲ | 4.63▼ |
| MA200 | 4.24▼ | 3.81▲ | 3.65▲ | 2.81▲ | 60.55▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.016▼ | -0.002▼ | -0.002▼ | -0.020▼ | 0.323▲ |
| RSI | 38.303▼ | 46.581▼ | 47.405▼ | 56.646▲ | 59.687▲ |
| STOCH | 34.799 | 64.518 | 67.032 | 65.152 | 86.917▲ |
| WILL %R | -100.000▼ | -80.769▼ | -69.118 | -45.455 | -15.244▲ |
| CCI | -147.876▼ | -132.245▼ | -114.574▼ | 45.713 | 113.202▲ |
|
Friday, November 14, 2025 01:11 PM
CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 4.01 | 4.4365 | 4.01 | 4.10 | 54,347 |
| 13/11/25 | 4.3117 | 4.50 | 4.07 | 4.27 | 57,015 |
| 12/11/25 | 4.14 | 4.47 | 3.95 | 4.39 | 51,554 |
| 11/11/25 | 4.15 | 4.48 | 3.99 | 4.13 | 64,400 |
| 10/11/25 | 4.27 | 4.515 | 4.04 | 4.16 | 71,259 |
| 07/11/25 | 4.35 | 4.60 | 3.50 | 4.25 | 311,278 |
| 06/11/25 | 4.13 | 4.45 | 4.07 | 4.45 | 122,200 |
| 05/11/25 | 3.76 | 4.25 | 3.7001 | 4.16 | 113,727 |
| 04/11/25 | 3.92 | 4.1399 | 3.62 | 3.77 | 70,466 |
| 03/11/25 | 4.16 | 4.24 | 3.90 | 3.94 | 70,200 |
|
|
||||
|
|
||||
|
|